Verastem Oncology to Present at the Stifel 2023 Virtual Targeted Oncology Days

Rhea-AI Summary

Verastem Oncology (Nasdaq: VSTM) has announced its participation in the Stifel 2023 Virtual Targeted Oncology Days, scheduled for April 25, 2023, at 2:30 p.m. ET. During the event, the company will present advancements in biopharmaceuticals aimed at treating cancer patients. A live webcast will be accessible on the company's website, www.verastem.com, with an archived replay available for 90 days after the event.

Verastem focuses on developing novel small molecule drugs targeting critical pathways that enable cancer cell survival and growth, specifically through RAF/MEK and FAK inhibition. For further details on their innovative pipeline and initiatives, visit their website.

BOSTON--(BUSINESS WIRE)-- Verastem Oncology, (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that the Company will present at the Stifel 2023 Virtual Targeted Oncology Days on Tuesday, April 25, 2023 at 2:30 p.m. ET.

A live webcast of the presentation will be available on the investors section of the Company’s website at www.verastem.com. An archived replay of the presentation will be made available on the same website for approximately 90 days following the presentation.

About Verastem Oncology

Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For more information, please visit www.verastem.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230418005208/en/

Investors:

Dan Calkins

Investor Relations

+1 781-469-1694

dcalkins@verastem.com

Nate LiaBraaten

+1 212-600-1902

nate@argotpartners.com

Media:

Lisa Buffington

Corporate Communications

+1 (781) 292-4205

lbuffington@verastem.com

Source: Verastem Oncology

FAQ

What is the date and time of Verastem's presentation at the Stifel 2023 Virtual Targeted Oncology Days?

Verastem will present on April 25, 2023, at 2:30 p.m. ET.

Where can I watch Verastem's presentation webcast?

The live webcast can be viewed on Verastem's website at www.verastem.com.

How long will the archived replay of Verastem's presentation be available?

The archived replay will be available for approximately 90 days following the presentation.

What is Verastem's focus in biopharmaceutical development?

Verastem focuses on developing new medicines that inhibit critical signaling pathways in cancer, including RAF/MEK and focal adhesion kinase (FAK) inhibition.

What trading symbol is associated with Verastem?

Verastem trades under the symbol 'VSTM' on Nasdaq.